Blockchain Registration Transaction Record

VERAXA Biotech Showcases BiTAC Platforms at BIO Convention

VERAXA Biotech (NASDAQ: VRXA) highlights BiTAC-ADC and BiTAC-TCE platforms at BIO International Convention, showcasing new proof-of-concept data for precise cancer treatment.

VERAXA Biotech Showcases BiTAC Platforms at BIO Convention

This news matters because VERAXA's BiTAC platforms represent a potential leap forward in cancer therapy, offering more precise treatment with fewer side effects. For patients and healthcare providers, these technologies could mean improved outcomes for solid tumors. For investors, the partnering opportunities at BIO signal potential growth and validation of VERAXA's pipeline, making it a stock to watch in the biotech sector.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x24712dc558515ad6f712f7f95a096c69a93371129622f3ecdae65b5e8f6d2139
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintbestuTr2-6e2b54162f77b5b0e91be101864c553f